04/26/2021
7:52 AM | Interpace Biosciences (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE
| |
04/05/2021
5:30 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2021
5:14 AM | Interpace Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2021
5:02 AM | Interpace Biosciences (Filer)
| Form NT 10-K
| |
03/12/2021
3:57 PM | Freeburg Thomas John (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2021
4:06 PM | Interpace Biosciences (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
02/04/2021
3:49 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2021
3:48 PM | Interpace Biosciences (Filer)
Interpace Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/21/2021
3:49 PM | 1315 Capital II, L.P. (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D/A
| |
01/20/2021
7:55 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/19/2021
8:43 PM | Interpace Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/19/2021
4:03 PM | Interpace Biosciences (Filer)
| Form 10-Q/A
| |
01/19/2021
3:59 PM | Interpace Biosciences (Filer)
| Form 10-Q/A
| |
01/19/2021
3:13 PM | Ampersand 2018 Limited Partnership (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D/A
| |
01/11/2021
3:50 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2020
8:49 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2020
4:02 PM | Interpace Biosciences (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
4:01 PM | Burnell Thomas W. (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
4:00 PM | Burnell Thomas W. (Reporting)
Interpace Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/25/2020
7:25 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2020
3:20 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2020
3:19 PM | Interpace Biosciences (Filer)
| Form NT 10-Q
| |
10/23/2020
3:01 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2020
7:35 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2020
4:13 PM | Interpace Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/14/2020
8:14 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2020
3:34 PM | Interpace Biosciences (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G
| |
08/20/2020
2:57 PM | Binsalamah Ziyad (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D/A
| |
08/20/2020
7:45 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2020
4:23 PM | Interpace Biosciences (Filer)
| Form NT 10-Q
| |
08/14/2020
4:22 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2020
8:10 AM | Binsalamah Ziyad (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D
| |
07/14/2020
3:20 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2020
9:50 AM | Gorman Robert J. (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2020
7:01 PM | Interpace Biosciences (Issuer)
SULLIVAN STEPHEN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2020
6:59 PM | Interpace Biosciences (Issuer)
Rocca Fortunato R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2020
6:58 PM | Interpace Biosciences (Issuer)
KEEGAN JOSEPH D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
7:06 AM | Interpace Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2020
4:13 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2020
8:42 PM | Interpace Biosciences (Filer)
| Form DEF 14A
| |
06/09/2020
1:36 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2020
8:47 PM | Interpace Biosciences (Filer)
| Form PRE 14A
| |
05/14/2020
8:55 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2020
7:15 AM | 1315 Capital II, L.P. (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D/A
| |
04/27/2020
3:55 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2020
3:20 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2020
10:56 AM | Interpace Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/17/2020
3:36 PM | Interpace Biosciences (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G
| |
04/06/2020
4:46 PM | Interpace Biosciences (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2020
10:32 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2020
9:19 AM | Interpace Biosciences (Issuer)
Lampe-Onnerud Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
9:18 AM | Interpace Biosciences (Issuer)
Lampe-Onnerud Christina (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/04/2020
9:15 AM | Interpace Biosciences (Issuer)
Marcet Pablo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
9:14 AM | Interpace Biosciences (Issuer)
Marcet Pablo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/03/2020
6:24 PM | Interpace Biosciences (Issuer)
Knechtel Fred S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2020
6:21 PM | Interpace Biosciences (Issuer)
Knechtel Fred S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/31/2020
3:22 PM | Gorman Robert J. (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2020
3:19 PM | Early James (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2020
3:18 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2020
3:10 PM | Interpace Biosciences (Filer)
| Form 8-K/A
| |
01/28/2020
3:09 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2020
3:29 PM | Interpace Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/24/2020
3:34 PM | Interpace Biosciences (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:30 PM | Interpace Biosciences (Issuer)
Richard Gregory (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2020
4:41 PM | 1315 Capital II, L.P. (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D
| |
01/23/2020
4:15 PM | 1315 Capital II, L.P. (Reporting)
Interpace Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/23/2020
4:12 PM | Chan Edward (Reporting)
Interpace Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2020
3:21 PM | Interpace Biosciences (Issuer)
McCarthy Laurence (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
3:20 PM | Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
3:15 PM | Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
7:30 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2020
11:55 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2020
6:34 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2019
3:15 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
3:33 PM | Interpace Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2019
11:25 AM | Interpace Biosciences (Filer)
| Form DEF 14A
| |
11/01/2019
3:41 PM | Interpace Biosciences (Filer)
| Form PRE 14A
| |
10/28/2019
3:19 PM | Interpace Biosciences (Issuer)
McCarthy Laurence (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/28/2019
3:18 PM | Gorman Robert J. (Reporting)
Interpace Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/21/2019
6:41 PM | Interpace Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/21/2019
6:34 PM | Interpace Biosciences (Filer)
| Form S-8 POS
| |
10/18/2019
3:22 PM | Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2019
3:15 PM | Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2019
3:20 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
4:17 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
3:40 PM | Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2019
3:38 PM | Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
3:46 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2019
3:43 PM | Interpace Biosciences (Filer)
| Form 424B5
| |
09/19/2019
8:49 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2019
8:26 PM | Interpace Biosciences (Filer)
| Form 8-K/A
| |
08/22/2019
3:28 PM | Interpace Biosciences (Filer)
| Form DEF 14A
| |
08/13/2019
3:46 PM | Interpace Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2019
7:42 AM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2019
8:21 PM | Interpace Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2019
8:00 PM | Interpace Biosciences (Filer)
| Form PRE 14A
| |
07/26/2019
7:15 PM | Interpace Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/25/2019
3:56 PM | Ampersand 2018 Limited Partnership (Filed by)
Interpace Biosciences (Subject)
| Form SC 13D
| |
07/25/2019
3:05 PM | Ampersand 2018 Limited Partnership (Reporting)
Interpace Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/25/2019
3:05 PM | Interpace Biosciences (Issuer)
Lev Eric B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
